Cargando…
Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity
[Image: see text] Introduction: Irbesartan (IBS), an angiotensin II receptor (AT1 subtype) antagonist which blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selective binding to AT1 angiotensin II receptor. It belongs to BCS class II drug (low aqueous solubility and...
Autores principales: | Puri, Vivek, Nagpal, Manju, Sharma, Ameya, Thakur, Gurjeet Singh, Singh, Manjinder, Aggarwal, Geeta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502911/ https://www.ncbi.nlm.nih.gov/pubmed/32983943 http://dx.doi.org/10.34172/bi.2020.34 |
Ejemplares similares
-
Improved antibacterial activity of topical gel-based on nanosponge carrier of cinnamon oil
por: Kaur, Malkiet, et al.
Publicado: (2021) -
Dissolution Improvement of Atorvastatin Calcium using Modified Locust Bean Gum by the Solid Dispersion Technique
por: Panghal, Dharmila, et al.
Publicado: (2014) -
Endothelial effects of antihypertensive treatment: focus on irbesartan
por: Negro, Roberto
Publicado: (2008) -
A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges
por: Puri, Vivek, et al.
Publicado: (2022) -
Chitosan-Based Polymer Blends for Drug Delivery Systems
por: Kaur, Malkiet, et al.
Publicado: (2023)